This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
We did a comprehensive review of all the initial public offerings for the biotech and pharmaceutical industry in 2021. This…
Article
1 year ago ●
4 mins read
A metabolite and its parent: same target inhibition, different mechanisms. PF-6870961 is a growth hormone secretagogue receptor 1a (GHSR1a) inverse…
molecule
7 months ago ●
6 mins read
It’s best to be first, but drugs that are approved later with the same mechanism of action can also create…
Article
1 year ago ●
8 mins read
A protein-protein interaction inhibitor for a challenging-to-drug master transcription factor. OICR12694 is an oral protein-protein interaction inhibitor targeting the challenging-to-drug…
molecule
7 months ago ●
5 mins read
In 2021 the FDA approved four new drugs for various immunological diseases, including a molecular glue, the first drug approved…
Article
1 year ago ●
9 mins read
A first-in-class drug for NASH? Resmetirom, an oral, liver-targeting, once-daily THR-β-selective agonist, recently made headlines for meeting both primary surrogate…
molecule
8 months ago ●
5 mins read
Load More
